The	DT	the dt NUPOS
JAK2	NN	JAK2 NN PennPOS
pathway	NN	pathway NN PennPOS
is	VBZ	be vbz NUPOS
activated	VBN	activate VBN PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

BACKGROUND	NN	background NN PennPOS
:	:	: : NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
the	DT	the dt NUPOS
most	RBS	much RBS PennPOS
rapidly	RB	rapid av-j NUPOS
progressive	JJ	progressive JJ PennPOS
and	CC	and cc NUPOS
fatal	JJ	fatal JJ PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
disorder	NN	disorder NN PennPOS
,	,	, , NUPOS
with	IN	with pp NUPOS
no	DT	no dx NUPOS
curative	JJ	curative JJ PennPOS
therapies	NNS	therapy NNS PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
signal-transducer-and-activator-of-transcription-3	NN	signal-transducer-and-activator-of-transcription-3 NN PennPOS
(	(	( ( NUPOS
STAT3	NN	STAT3 NN PennPOS
)	)	) ) NUPOS
protein	NN	protein NN PennPOS
is	VBZ	be vbz NUPOS
activated	VBN	activate VBN PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
and	CC	and cc NUPOS
alveolar	JJ	alveolar JJ PennPOS
type	NN	type NN PennPOS
II	CD	II crd NUPOS
cells	NNS	cell NNS PennPOS
(	(	( ( NUPOS
ATII	NN	ATII NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
thereby	RB	thereby av NUPOS
contributing	VBG	contribute VBG PennPOS
to	TO	to p-acp NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

Although	IN	although cs NUPOS
activation	NN	activation NN PennPOS
of	IN	of pp-f NUPOS
Janus-kinase-2	NN	Janus-kinase-2 NN PennPOS
(	(	( ( NUPOS
JAK2	NN	JAK2 NN PennPOS
)	)	) ) NUPOS
has	VBZ	have vdz NUPOS
been	VBN	be vbn NUPOS
implicated	VBN	implicate VBN PennPOS
in	IN	in IN PennPOS
proliferative	JJ	proliferative JJ PennPOS
disorders	NNS	disorder NNS PennPOS
,	,	, , NUPOS
its	PRP$	its po31 NUPOS
role	NN	role NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
is	VBZ	be vbz NUPOS
unknown	JJ	unknown JJ PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
aim	NN	aim NN PennPOS
of	IN	of pp-f NUPOS
this	DT	this d NUPOS
study	NN	study NN PennPOS
was	VBD	be vbd NUPOS
to	TO	to p-acp NUPOS
analyze	VB	analyze VBP PennPOS
JAK2	NN	JAK2 NN PennPOS
activation	NN	activation NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
to	TO	to p-acp NUPOS
determine	VB	determine VBP PennPOS
whether	IN	whether cs NUPOS
JAK2/STAT3	NN	JAK2/STAT3 NN PennPOS
inhibition	NN	inhibition NN PennPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
potential	JJ	potential JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
strategy	NN	strategy NN PennPOS
for	IN	for c-acp NUPOS
this	DT	this d NUPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

METHODS	NNS	method NNS PennPOS
AND	CC	and cc NUPOS
RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
JAK2/p-JAK	NN	JAK2/p-JAK NN PennPOS
2	CD	2 crd NUPOS
and	CC	and cc NUPOS
STAT3/pSTAT3	NN	STAT3/pSTAT3 NN PennPOS
expression	NN	expression NN PennPOS
was	VBD	be vbd NUPOS
evaluated	VBN	evaluate VBN PennPOS
using	VBG	use VBG PennPOS
quantitative	JJ	quantitative JJ PennPOS
real	JJ	real JJ PennPOS
time-PCR	NN	time-PCR NN PennPOS
,	,	, , NUPOS
western	NN	western NN PennPOS
blotting	NN	blotting NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
immunohistochemistry	NN	immunohistochemistry NN PennPOS
.	.	. . NUPOS

Compared	VBN	compare VBN PennPOS
to	TO	to p-acp NUPOS
human	JJ	human JJ PennPOS
healthy	JJ	healthy JJ PennPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
(	(	( ( NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
10	CD	10 crd NUPOS
)	)	) ) NUPOS
both	DT	both d NUPOS
proteins	NNS	protein NNS PennPOS
were	VBD	be vbd NUPOS
upregulated	VBN	upregulate VBN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
n	NN	n NN PennPOS
=	JJ	= JJ PennPOS
12	CD	12 crd NUPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Stimulating	VBG	stimulate VBG PennPOS
primary	JJ	primary JJ PennPOS
ATII	NN	ATII NN PennPOS
and	CC	and cc NUPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
with	IN	with pp NUPOS
transforming-growth-factor-beta-1	NN	transforming-growth-factor-beta-1 NN PennPOS
or	CC	or cc NUPOS
interleukin	NN	interleukin NN PennPOS
(	(	( ( NUPOS
IL	NN	IL NN PennPOS
)	)	) ) NUPOS
-6	CD	-6 CD PennPOS
/	:	/ : NUPOS
IL-13	NN	IL-13 NN PennPOS
activated	VBD	activate VBD PennPOS
JAK2	NN	JAK2 NN PennPOS
and	CC	and cc NUPOS
STAT3	NN	STAT3 NN PennPOS
,	,	, , NUPOS
inducing	VBG	induce VBG PennPOS
epithelial	JJ	epithelial JJ PennPOS
to	TO	to p-acp NUPOS
mesenchymal	JJ	mesenchymal JJ PennPOS
and	CC	and cc NUPOS
fibroblast	NN	fibroblast NN PennPOS
to	TO	to p-acp NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
transitions	NNS	transition NNS PennPOS
.	.	. . NUPOS

Dual	JJ	dual JJ PennPOS
p-JAK2	NN	p-JAK2 NN PennPOS
/	:	/ : NUPOS
p-STAT3	NN	p-STAT3 NN PennPOS
inhibition	NN	inhibition NN PennPOS
with	IN	with pp NUPOS
JSI-124	NN	JSI-124 NN PennPOS
or	CC	or cc NUPOS
silencing	NN	silencing NN PennPOS
of	IN	of pp-f NUPOS
JAK2	NN	JAK2 NN PennPOS
and	CC	and cc NUPOS
STAT3	NN	STAT3 NN PennPOS
genes	NNS	gene NNS PennPOS
suppressed	VBD	suppress VBD PennPOS
ATII	NN	ATII NN PennPOS
and	CC	and cc NUPOS
the	DT	the dt NUPOS
fibroblast	NN	fibroblast NN PennPOS
to	TO	to p-acp NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
transition	NN	transition NN PennPOS
,	,	, , NUPOS
with	IN	with pp NUPOS
greater	JJR	great JJR PennPOS
effects	NNS	effect NNS PennPOS
than	IN	than cs NUPOS
the	DT	the dt NUPOS
sum	NN	sum NN PennPOS
of	IN	of pp-f NUPOS
those	DT	those d NUPOS
obtained	VBN	obtain VBN PennPOS
using	VBG	use VBG PennPOS
JAK2	NN	JAK2 NN PennPOS
or	CC	or cc NUPOS
STAT3	NN	STAT3 NN PennPOS
inhibitors	NNS	inhibitor NNS PennPOS
individually	RB	individual av-jn NUPOS
.	.	. . NUPOS

Dual	JJ	dual JJ PennPOS
rather	RB	rather av-c NUPOS
than	IN	than cs NUPOS
single	JJ	single JJ PennPOS
inhibition	NN	inhibition NN PennPOS
was	VBD	be vbd NUPOS
also	RB	also av NUPOS
more	RBR	much RBR PennPOS
effective	JJ	effective JJ PennPOS
for	IN	for c-acp NUPOS
inhibiting	VBG	inhibit VBG PennPOS
fibroblast	NN	fibroblast NN PennPOS
migration	NN	migration NN PennPOS
,	,	, , NUPOS
preventing	VBG	prevent VBG PennPOS
increases	NNS	increase NNS PennPOS
in	IN	in IN PennPOS
fibroblast	NN	fibroblast NN PennPOS
senescence	NN	senescence NN PennPOS
and	CC	and cc NUPOS
Bcl-2	NN	Bcl-2 NN PennPOS
expression	NN	expression NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
ameliorating	VBG	ameliorate VBG PennPOS
impaired	JJ	impaired JJ PennPOS
autophagy	NN	autophagy NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
rats	NNS	rat NNS PennPOS
administered	VBN	administer VBN PennPOS
JSI-124	NN	JSI-124 NN PennPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
dual	JJ	dual JJ PennPOS
inhibitor	NN	inhibitor NN PennPOS
of	IN	of pp-f NUPOS
p-JAK2	NN	p-JAK2 NN PennPOS
/	:	/ : NUPOS
p-STAT3	NN	p-STAT3 NN PennPOS
,	,	, , NUPOS
at	IN	at pp NUPOS
a	DT	a dt NUPOS
dose	NN	dose NN PennPOS
of	IN	of pp-f NUPOS
1	CD	1 crd NUPOS
mg/kg/day	NN	mg/kg/day NN PennPOS
,	,	, , NUPOS
bleomycin-induced	JJ	bleomycin-induced JJ PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
was	VBD	be vbd NUPOS
reduced	VBN	reduce VBN PennPOS
and	CC	and cc NUPOS
collagen	NN	collagen NN PennPOS
deposition	NN	deposition NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
was	VBD	be vbd NUPOS
inhibited	VBN	inhibit VBN PennPOS
,	,	, , NUPOS
as	IN	as c-acp NUPOS
were	VBD	be vbd NUPOS
JAK2	NN	JAK2 NN PennPOS
and	CC	and cc NUPOS
STAT3	NN	STAT3 NN PennPOS
activation	NN	activation NN PennPOS
and	CC	and cc NUPOS
several	JJ	several JJ PennPOS
markers	NNS	marker NNS PennPOS
of	IN	of pp-f NUPOS
fibrosis	NN	fibrosis NN PennPOS
,	,	, , NUPOS
autophagy	NN	autophagy NN PennPOS
,	,	, , NUPOS
senescence	NN	senescence NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
anti-apoptosis	JJ	anti-apoptosis JJ PennPOS
.	.	. . NUPOS

CONCLUSIONS	NNS	conclusion NNS PennPOS
:	:	: : NUPOS
JAK2	NN	JAK2 NN PennPOS
and	CC	and cc NUPOS
STAT3	NN	STAT3 NN PennPOS
are	VBP	be vbb NUPOS
activated	VBN	activate VBN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
their	PRP$	their po32 NUPOS
dual	JJ	dual JJ PennPOS
inhibition	NN	inhibition NN PennPOS
may	MD	may vmb NUPOS
be	VB	be vbi NUPOS
an	DT	a dt NUPOS
attractive	JJ	attractive JJ PennPOS
strategy	NN	strategy NN PennPOS
for	IN	for c-acp NUPOS
treating	VBG	treat VBG PennPOS
this	DT	this d NUPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

